software, version 8.2 (SAS institute)
90
Structured Review
SAS institute
software, version 8.2
Software, Version 8.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phred+computer+program/software+version+8+2/pmc01895819-64-12-14
Average 90 stars, based on 1 article reviews
Software, Version 8.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phred+computer+program/software+version+8+2/pmc01895819-64-12-14
Average 90 stars, based on 1 article reviews
software, version 8.2 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial. Article Snippet: The HOPE CLTI-2 trial was a phase 3, multicenter, double-blind, placebo-controlled study aimed to evaluate the efficacy and safety of seltoplasmid in patients with Rutherford class 5 CLTI.. This study did not require participants to be ineligible for revascularization, allowing enrollment of patients with CLTI caused by either atherosclerosis (ASO) or Buerger disease (or thromboangiitis obliterans [TAO]).. The primary endpoint was the complete ulcer healing rate at 6 months. Article Title: Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP-1RA in CHB and T2DM Patients. Article Snippet: Background: The prevalence of diabetes is increasing among chronic hepatitis B (CHB) patients.. However, the relative efficacy of sodiumglucose cotransporter2 inhibitors (SGLT2i) or dipeptidyl peptidase4 inhibitors (DPP4i), compared with glucagonlike peptide1 receptor agonists (GLP1RA), among such atrisk populations remains unclear in terms of reducing liverrelated events Article Title: Exogenous mitochondria added on benefits for cellular prion protein overexpression in adipose-derived mesenchymal stem cells treatment on intracranial hemorrhage rat. Article Snippet: Article Title: Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study. Article Snippet: METHODS: We included participants aged 40–79 years receiving a national health checkup from 2009 to 2010 in the Republic of Korea, classified as follows: non-MASLD, MASLD, MASLD with increased alcohol intake (MetALD; weekly alcohol 210–420 g for male and 140–350 g for female individuals), and alcohol-associated liver disease (ALD; excessive alcohol intake with weekly alcohol ‡420 g for male or ‡350 g for female individuals).. The primary outcomewasHCC incidence.. HCC risk was estimated using multivariable Cox proportional hazard models. Article Title: Optimal BMI cutoff for lean MASLD/MetALD and adverse hepatic outcomes in East-Asian populations. Article Snippet: Nonalcoholic fatty liver disease (NAFLD) is a primary contributor to hepatocellular carcinoma (HCC)/liver cirrhosis (LC), affecting ~30 % of the global population.. Its incidence is rising parallel to increasing prevalences of metabolic syndrome and obesity [1,2].. Although obesity primarily contributes to NAFLD, approximately 3~40 % of NAFLD patients are lean and 20 % in lean population have NAFLD [3]. Article Title: Robotic-assisted carotid artery stenting with R-One TM : Feasibility and safety assessment in patients with carotid web lesions. Article Snippet: Purpose: Robotic-assisted carotid artery stenting (CAS) procedures are on the rise and have demonstrated benefits compared to manual intervention.. The R-OneTM robotic platform has demonstrated safety and efficacy for percutaneous coronary interventions, but its utility for procedures in the common carotid artery has not been thoroughly studied.. This study aims to assess the feasibility and initial safety of the R-OneTM robotic platform for treating patients with carotid artery disease (CAD) presenting with carotid web-diaphragm lesions. Article Title: Additional benefits of combined ceftriaxone and adipose-derived mesenchymal stem cells on revamping the outcomes in rodent after acute spinal infection. Article Snippet: Software:Article Title: More Evidence that Surgical Intervention for Unstable Distal Radius Fracture in Elderly Does not Offer a Superior Patient Perceived Functional Advantage over Time Honored Conservative Treatment in Long Term Follow-Up: A Critical Appraisal at 10 Years (Range 10–13 Years) Follow-up Study Article Snippet: .. Data analysis was completed using |